Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD

被引:30
|
作者
Sun, D-Q [1 ,2 ]
Ye, F-Z [3 ,4 ]
Kani, H. T. [5 ]
Yang, J-R [6 ]
Zheng, K., I [3 ]
Zhang, H-Y [7 ]
Targher, G. [8 ,9 ]
Byrne, C. D. [10 ]
Chen, Y-P [3 ,11 ,13 ]
Yuan, W-J [2 ]
Yilmaz, Y. [5 ,12 ]
Zheng, M-H [3 ,11 ]
机构
[1] Nanjing Med Univ, Affiliated Wuxi 2 Peoples Hosp, Dept Nephrol, Wuxi, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Shanghai Gen Hosp, Dept Nephrol, Shanghai, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, NAFLD Res Ctr, Dept Hepatol, 2 Fuxue Lane, Wenzhou 325000, Peoples R China
[4] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou, Peoples R China
[5] Marmara Univ, Sch Med, Dept Gastroenterol, TR-34662 Istanbul, Turkey
[6] Wenzhou Med Univ, Affiliated Hosp 1, Dept Clin Lab, Wenzhou, Peoples R China
[7] Sun Yat Sen Univ, Sch Biomed Engn, Guangzhou, Peoples R China
[8] Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, Verona, Italy
[9] Azienda Osped Univ Integrata Verona, Verona, Italy
[10] Univ Hosp Southampton, Southampton Gen Hosp, Southampton Natl Inst Hlth Res, Biomed Res Ctr, Southampton, Hants, England
[11] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[12] Marmara Univ, Inst Gastroenterol, Istanbul, Turkey
[13] Key Lab Diag & Treatment Dev Chron Liver Dis Zhej, Wenzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Early kidney dysfunction; Liver fibrosis; Liver stiffness measurement; Non-alcoholic fatty liver disease; INSULIN-RESISTANCE; DISEASE; RISK; MICROALBUMINURIA; STEATOHEPATITIS; STRESS;
D O I
10.1016/j.diabet.2019.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. - The association between Liver fibrosis (LF), as assessed by either histology or Liver stiffness measurement (LSM), and the presence of Early kidney dysfunction (EKD) was investigated in this study, as was also the diagnostic performance of LSM for identifying the presence of EKD in patients with Nonalcoholic fatty liver disease (NAFLD). Materials and methods. - A total of 214 adults with non-cirrhotic biopsy-proven NAFLD were recruited from two independent medical centres. Their histological stage of LF was quantified using Brunt's criteria. Vibration-controlled Transient elastography (TE), using M-p robe ( Fib roScan (R)) ultrasound, was performed in 154 patients and defined as significant when LSM was >= 8.0 kPa. EKD was defined as the presence of microalbuminuria with an estimated glomerular filtration rate >= 60 mL/min/1.73 m(2). Logistic regression modelling was used to estimate the likelihood of having EKD with NAFLD (LSM-EKD model). Results. - The prevalence of EKD was higher in patients with vs without LF on histology (22.14% vs 4.82%, respectively; P < 0.001) and, similarly, EKD prevalence was higher in patients with LSM >= 8.0 kPa vs LSM < 8.0 kPa (23.81% vs 6.59%, respectively; P < 0.05). The area under the ROC curve of the LSM-EKD model for identifying EKD was 0.80 (95% CI: 0.72-0.89). LF detected by either method was associated with EKD independently of established renal risk factors and potential confounders. Conclusion. - LF was independently associated with EKD in patients with biopsy-proven NAFLD. Thus, TE-measured LSM, a widely used technique for quantifying LF, can accurately identify those patients with NAFLD who are at risk of having EKD. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:288 / 295
页数:8
相关论文
共 50 条
  • [1] Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
    Koch, Alexander
    Horn, Andreas
    Dueckers, Hanna
    Yagmur, Eray
    Sanson, Edouard
    Bruensing, Jan
    Buendgens, Lukas
    Voigt, Sebastian
    Trautwein, Christian
    Tacke, Frank
    CRITICAL CARE, 2011, 15 (06):
  • [2] Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
    Alexander Koch
    Andreas Horn
    Hanna Dückers
    Eray Yagmur
    Edouard Sanson
    Jan Bruensing
    Lukas Buendgens
    Sebastian Voigt
    Christian Trautwein
    Frank Tacke
    Critical Care, 15
  • [3] Etiology Dependent Elevations in Liver Stiffness Measurements in Patients With Non-cirrhotic Portal Hypertension
    Martinez, Melissa
    Ghabril, Marwan
    Chalasani, Naga
    Vuppalanchi, Raj
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S865 - S865
  • [4] PREDICTIVE MODELS FOR HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT IN CIRRHOTIC AND NON-CIRRHOTIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE PATIENTS
    Vatsavayi, Prerana Sruthi
    Aziz, Jawad
    Abdurrahman, Mohammed
    Yee, Michael
    Mullish, Benjamin
    Forlano, Roberta
    Khan, Shahid
    Manousou, Pinelopi
    HEPATOLOGY, 2024, 80 : S856 - S856
  • [5] Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
    Akbari, Camilla
    Dodd, Maja
    Stal, Per
    Nasr, Patrik
    Ekstedt, Mattias
    Kechagias, Stergios
    Vessby, Johan
    Rorsman, Fredrik
    Zhang, Xiao
    Wang, Tongtong
    Jemielita, Thomas
    Fernandes, Gail
    Engel, Samuel S.
    Hagstrom, Hannes
    Shang, Ying
    JHEP REPORTS, 2024, 6 (02)
  • [6] Poor diet quality is associated with higher cardiovascular risk in a cohort of non-cirrhotic Italian MASLD (Metabolic dysfunction associated steatotic liver disease) outpatients
    Chen, Rusi
    Abbati, Chiara
    Santangeli, Ernestina
    Capelli, Roberta
    Leoni, Simona
    Ravaioli, Federico
    Piscaglia, Fabio
    Ferri, Silvia
    JOURNAL OF HEPATOLOGY, 2024, 80 : S499 - S499
  • [7] Long-term liver-related outcomes in 1,260 patients with non-cirrhotic NAFLD
    Akbari, Camilla
    Dodd, Maja
    Zhang, Xiao
    Wang, Tongtong
    Jemielita, Thomas
    Fernandes, Gail
    Engel, Samuel
    Nasr, Patrik
    Vessby, Johan
    Rorsman, Fredrik
    Kechagias, Stergios
    Stal, Per
    Ekstedt, Mattias
    Hagstrom, Hannes
    Shang, Ying
    JOURNAL OF HEPATOLOGY, 2023, 78 : S650 - S651
  • [8] Liver stiffness measurement by SuperSonic Imagine twodimensional shear wave elastography to predict hepatocellular carcinoma in non-cirrhotic metabolic dysfunction-associated steatotic liver disease
    Indre, M. G.
    Stefanini, B.
    Abbati, C.
    Boe, M.
    Cappelli, R.
    Chen, R.
    Santangeli, E.
    Tovoli, F.
    Morelli, M. C.
    Piscaglia, F.
    Ferri, S.
    Ravaioli, F.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [9] Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease
    Shang, Ying
    Akbari, Camilla
    Dodd, Maja
    Zhang, Xiao
    Wang, Tongtong
    Jemielita, Thomas
    Fernandes, Gail
    Engel, Samuel S.
    Nasr, Patrik
    Vessby, Johan
    Rorsman, Fredrik
    Kechagias, Stergios
    Stal, Per
    Ekstedt, Mattias
    Hagstrom, Hannes
    HEPATOLOGY, 2024,
  • [10] REVERSAL OF NEUROCOGNITIVE DYSFUNCTION IN NON-CIRRHOTIC HCV INFECTED PATIENTS; IMPACT OF DAA'S BEYOND THE LIVER
    Strahan, Orla
    Ferguson, Damien
    Coen, Robert
    Dockree, Paul
    Doherty, Colin
    O'Gorman, Philip
    Gormley, John
    McKiernan, Susan Mary
    Bergin, Colm
    Norris, Suzanne
    HEPATOLOGY, 2019, 70 : 987A - 987A